세포 동결보존 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Cell Cryopreservation Market Summary

The global cell cryopreservation market size was estimated at USD 3.38 billion in 2024 and is projected to reach USD 8.86 billion by 2033, growing at a CAGR of 11.40% from 2025 to 2033. The market growth is due to the increasing adoption of cell cryopreservation as an alternative to conventional freezing techniques.

Moreover, rising demand for effective freezing media across various end users and a wide range of new products is anticipated to fuel the market growth.

Fertility preservation

Fertility preservation is emerging as a significant market driver for the cell cryopreservation industry, owing to the growing adoption of assisted reproductive technologies (ART) and the rising prevalence of infertility cases. Moreover, many individuals delay parenthood due to career priorities, lifestyle choices, and late marriages, further accelerating the need for cryopreservation solutions. The trend is supported by advancements in cryoprotectants, vitrification techniques, and cell freezing media, ensuring higher post-thaw survival rates of oocytes, sperm, and embryos.

Global Cell Cryopreservation Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the global cell cryopreservation market on the basis of product, application, end-use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Cell Freezing Media
  • Ethylene Glycol
  • Dimethyl Sulfoxide
  • Glycerol
  • Others
• Equipment
  • Freezers
  • Incubators
  • Liquid Nitrogen Supply Tanks
• Consumables
  • Cryogenic vials
  • Cryogenic tubes
  • Cooler boxes/containers
  • Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Stem Cells
• Reproductive Cells
• Bioproduction Cell Lines
• Primary Cells
• Others
• End-use Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Biopharmaceutical & Pharmaceutical Companies
• Academic and Research Institutes
• Biobanks
• IVF Clinics
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Product Segment
  • 1.2.2. Application Segment
  • 1.2.3. End Use Segment
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Impact Analysis
    • 3.3.1.1. Fertility preservation
    • 3.3.1.2. Growth in cell and gene therapy
  • 3.3.2. Market Restraint Analysis
    • 3.3.2.1. High cost of equipment
• 3.4. Business Environment Analysis
  • 3.4.1. PESTEL Analysis
  • 3.4.2. Porter's Five Forces Analysis

Chapter 4. Product Business Analysis

• 4.1. Global Cell Cryopreservation Market: Product Movement Analysis
• 4.2. Cell Freezing Media
  • 4.2.1. Cell Freezing Media Market, 2021 - 2033 (USD Million)
  • 4.2.2. Ethylene Glycol
    • 4.2.2.1. Ethylene Glycol Market, 2021 - 2033 (USD Million)
  • 4.2.3. Dimethyl Sulfoxide
    • 4.2.3.1. Dimethyl Sulfoxide Market, 2021 - 2033 (USD Million)
  • 4.2.4. Glycerol
    • 4.2.4.1. Glycerol Market, 2021 - 2033 (USD Million)
  • 4.2.5. Others
    • 4.2.5.1. Others Market, 2021 - 2033 (USD Million)
• 4.3. Equipment
  • 4.3.1. Equipment Market, 2021 - 2033 (USD Million)
  • 4.3.2. Freezers
    • 4.3.2.1. Freezers Market, 2021 - 2033 (USD Million)
  • 4.3.3. Incubators
    • 4.3.3.1. Incubators Market, 2021 - 2033 (USD Million)
  • 4.3.4. Liquid Nitrogen Supply Tanks
    • 4.3.4.1. Liquid Nitrogen Supply Tanks Market, 2021 - 2033 (USD Million)
• 4.4. Consumables
  • 4.4.1. Consumables Market, 2021 - 2033 (USD Million)
  • 4.4.2. Cryogenic vials
    • 4.4.2.1. Cryogenic vials Market, 2021 - 2033 (USD Million)
  • 4.4.3. Cryogenic tubes
    • 4.4.3.1. Cryogenic tubes Market, 2021 - 2033 (USD Million)
  • 4.4.4. Cooler boxes/containers
    • 4.4.4.1. Cooler boxes/containers Market, 2021 - 2033 (USD Million)
  • 4.4.5. Others
    • 4.4.5.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. Application Business Analysis

• 5.1. Global Cell Cryopreservation Market: Application Movement Analysis
• 5.2. Stem Cells
  • 5.2.1. Stem Cells Market, 2021 - 2033 (USD Million)
• 5.3. Reproductive Cells
  • 5.3.1. Reproductive Cells Market, 2021 - 2033 (USD Million)
• 5.4. Bioproduction Cell Lines
  • 5.4.1. Bioproduction Cell Lines Market, 2021 - 2033 (USD Million)
• 5.5. Primary Cells
  • 5.5.1. Primary Cells Market, 2021 - 2033 (USD Million)
• 5.6. Others
  • 5.6.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. End Use Business Analysis

• 6.1. Global Cell Cryopreservation Market: End Use Movement Analysis
• 6.2. Biopharmaceutical & Pharmaceutical Companies
  • 6.2.1. Biopharmaceutical & Pharmaceutical Companies Market, 2021 - 2033 (USD Million)
• 6.3. Academic and Research Institutes
  • 6.3.1. Academic and Research Institutes Market, 2021 - 2033 (USD Million)
• 6.4. Biobanks
  • 6.4.1. Biobanks Market, 2021 - 2033 (USD Million)
• 6.5. IVF clinics
  • 6.5.1. IVF clinics Market, 2021 - 2033 (USD Million)
• 6.6. Others
  • 6.6.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. Regional Business Analysis

• 7.1. Global Cell Cryopreservation Market Share By Region, 2023 & 2033
• 7.2. North America
  • 7.2.1. North America Cell Cryopreservation Market, 2021 - 2033 (USD Million)
  • 7.2.2. U.S.
    • 7.2.2.1. Key Country Dynamics
    • 7.2.2.2. Competitive Scenario
    • 7.2.2.3. Target Disease Prevalence
    • 7.2.2.4. U.S. Cell Cryopreservation Market, 2021 - 2033 (USD Million)
  • 7.2.3. Canada
    • 7.2.3.1. Key Country Dynamics
    • 7.2.3.2. Competitive Scenario
    • 7.2.3.3. Target Disease Prevalence
    • 7.2.3.4. Canada Cell Cryopreservation Market, 2021 - 2033 (USD Million)
  • 7.2.4. Mexico
    • 7.2.4.1. Key Country Dynamics
    • 7.2.4.2. Competitive Scenario
    • 7.2.4.3. Target Disease Prevalence
    • 7.2.4.4. Mexico Cell Cryopreservation Market, 2021 - 2033 (USD Million)
• 7.3. Europe
  • 7.3.1. Europe Cell Cryopreservation Market, 2021 - 2033 (USD Million)
  • 7.3.2. Germany
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Competitive Scenario
    • 7.3.2.3. Target Disease Prevalence
    • 7.3.2.4. Germany Cell Cryopreservation Market, 2021 - 2033 (USD Million)
  • 7.3.3. UK
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Competitive Scenario
    • 7.3.3.3. Target Disease Prevalence
    • 7.3.3.4. UK Cell Cryopreservation Market, 2021 - 2033 (USD Million)
  • 7.3.4. France
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Competitive Scenario
    • 7.3.4.3. Target Disease Prevalence
    • 7.3.4.4. France Cell Cryopreservation Market, 2021 - 2033 (USD Million)
  • 7.3.5. Italy
    • 7.3.5.1. Key Country Dynamics
    • 7.3.5.2. Competitive Scenario
    • 7.3.5.3. Target Disease Prevalence
    • 7.3.5.4. Italy Cell Cryopreservation Market, 2021 - 2033 (USD Million)
  • 7.3.6. Spain
    • 7.3.6.1. Key Country Dynamics
    • 7.3.6.2. Competitive Scenario
    • 7.3.6.3. Target Disease Prevalence
    • 7.3.6.4. Spain Cell Cryopreservation Market, 2021 - 2033 (USD Million)
  • 7.3.7. Denmark
    • 7.3.7.1. Key Country Dynamics
    • 7.3.7.2. Competitive Scenario
    • 7.3.7.3. Target Disease Prevalence
    • 7.3.7.4. Denmark Cell Cryopreservation Market, 2021 - 2033 (USD Million)
  • 7.3.8. Sweden
    • 7.3.8.1. Key Country Dynamics
    • 7.3.8.2. Competitive Scenario
    • 7.3.8.3. Target Disease Prevalence
    • 7.3.8.4. Sweden Cell Cryopreservation Market, 2021 - 2033 (USD Million)
  • 7.3.9. Norway
    • 7.3.9.1. Key Country Dynamics
    • 7.3.9.2. Competitive Scenario
    • 7.3.9.3. Target Disease Prevalence
    • 7.3.9.4. Norway Cell Cryopreservation Market, 2021 - 2033 (USD Million)
• 7.4. Asia Pacific
  • 7.4.1. Asia Pacific Cell Cryopreservation Market, 2021 - 2033 (USD Million)
  • 7.4.2. Japan
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Target Disease Prevalence
    • 7.4.2.4. Japan Cell Cryopreservation Market, 2021 - 2033 (USD Million)
  • 7.4.3. China
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Target Disease Prevalence
    • 7.4.3.4. China Cell Cryopreservation Market, 2021 - 2033 (USD Million)
  • 7.4.4. India
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Target Disease Prevalence
    • 7.4.4.4. India Cell Cryopreservation Market, 2021 - 2033 (USD Million)
  • 7.4.5. South Korea
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Competitive Scenario
    • 7.4.5.3. Target Disease Prevalence
    • 7.4.5.4. South Korea Cell Cryopreservation Market, 2021 - 2033 (USD Million)
  • 7.4.6. Australia
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Competitive Scenario
    • 7.4.6.3. Target Disease Prevalence
    • 7.4.6.4. Australia Cell Cryopreservation Market, 2021 - 2033 (USD Million)
  • 7.4.7. Thailand
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Competitive Scenario
    • 7.4.7.3. Target Disease Prevalence
    • 7.4.7.4. Thailand Cell Cryopreservation Market, 2021 - 2033 (USD Million)
• 7.5. Latin America
  • 7.5.1. Latin America Cell Cryopreservation Market, 2021 - 2033 (USD Million)
  • 7.5.2. Brazil
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Target Disease Prevalence
    • 7.5.2.4. Brazil Cell Cryopreservation Market, 2021 - 2033 (USD Million)
  • 7.5.3. Argentina
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Target Disease Prevalence
    • 7.5.3.4. Argentina Cell Cryopreservation Market, 2021 - 2033 (USD Million)
• 7.6. MEA
  • 7.6.1. MEA Cell Cryopreservation Market, 2021 - 2033 (USD Million)
  • 7.6.2. South Africa
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Target Disease Prevalence
    • 7.6.2.4. South Africa Cell Cryopreservation Market, 2021 - 2033 (USD Million)
  • 7.6.3. Saudi Arabia
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Target Disease Prevalence
    • 7.6.3.4. Saudi Arabia Cell Cryopreservation Market, 2021 - 2033 (USD Million)
  • 7.6.4. UAE
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Target Disease Prevalence
    • 7.6.4.4. UAE Cell Cryopreservation Market, 2021 - 2033 (USD Million)
  • 7.6.5. Kuwait
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Target Disease Prevalence
    • 7.6.5.4. Kuwait Cell Cryopreservation Market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
• 8.2. Strategy Mapping
• 8.3. Company Position Analysis, 2024
• 8.4. Company Profiles/Listing
  • 8.4.1. Thermo Fisher Scientific Inc.
    • 8.4.1.1. Overview
    • 8.4.1.2. Financial Performance
    • 8.4.1.3. Product Benchmarking
    • 8.4.1.4. Strategic Initiatives
  • 8.4.2. PromoCell GmbH
    • 8.4.2.1. Overview
    • 8.4.2.2. Product Benchmarking
    • 8.4.2.3. Strategic Initiatives
  • 8.4.3. Merck KGaA
    • 8.4.3.1. Overview
    • 8.4.3.2. Financial Performance
    • 8.4.3.3. Product Benchmarking
    • 8.4.3.4. Strategic Initiatives
  • 8.4.4. Sartorius AG
    • 8.4.4.1. Overview
    • 8.4.4.2. Financial Performance
    • 8.4.4.3. Product Benchmarking
    • 8.4.4.4. Strategic Initiatives
  • 8.4.5. Lonza
    • 8.4.5.1. Overview
    • 8.4.5.2. Financial Performance
    • 8.4.5.3. Product Benchmarking
    • 8.4.5.4. Strategic Initiatives
  • 8.4.6. Corning Incorporated
    • 8.4.6.1. Overview
    • 8.4.6.2. Financial Performance
    • 8.4.6.3. Product Benchmarking
    • 8.4.6.4. Strategic Initiatives
  • 8.4.7. Creative Biolabs
    • 8.4.7.1. Overview
    • 8.4.7.2. Product Benchmarking
    • 8.4.7.3. Strategic Initiatives
  • 8.4.8. BioLife Solutions Inc.
    • 8.4.8.1. Overview
    • 8.4.8.2. Financial Performance
    • 8.4.8.3. Product Benchmarking
    • 8.4.8.4. Strategic Initiatives
  • 8.4.9. HiMedia Laboratories
    • 8.4.9.1. Overview
    • 8.4.9.2. Product Benchmarking
    • 8.4.9.3. Strategic Initiatives